查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
早產及PROM檢驗的全球市場 (2022～2030年):成長、未來展望、競爭分析
市場調查報告書
商品編碼
1162482

早產及PROM檢驗的全球市場 (2022～2030年):成長、未來展望、競爭分析

Preterm Birth And PROM Testing Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

早產及PROM檢驗的市場規模，從2022年到2030年的預測期間內預計以2.1％的年複合成長率成長。

由於出色的診斷準確度與靈敏度，PROM檢測套組的生物標記預期普及。胎兒球蛋白檢驗 (AFT) 、胰島素樣成長因素結合蛋白質-1 (IGFBP-1) 、胎盤Alpha巨球蛋白-1 (PAMG-1) 等生物標記這10年非常受到關注。出色的診斷準確度和靈敏度，提高PROM檢測套組的生物標記的人氣。

本報告提供全球早產及PROM檢驗的市場調查，市場概要，市場成長的各種影響因素分析，市場規模的變化、預測，各種區分、各地區/主要國家的明細，主要企業簡介等彙整資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 早產及PROM檢驗市場:事業預測、市場動態

  • 世界市場規模:2020年～2030年
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素、阻礙因素的影響分析
  • See-Saw分析
  • 波特的五力分析
  • PESTEL分析

第4章 早產及PROM檢驗市場:各檢查

  • 市場概要
  • 成長、收益分析
  • 市場分類
    • 婦科檢查
    • 羊齒書結晶形成檢驗
    • Nitrazine試驗
    • 匯集檢驗
    • 超音波檢驗
    • 子宮監測檢驗
    • 生物標記

第5章 北美的早產及PROM檢驗市場

  • 市場概要
  • 早產及PROM檢驗市場:各檢查
  • 早產及PROM檢驗市場:各地區

第6章 英國及EU的早產及PROM檢驗市場

  • 市場概要
  • 早產及PROM檢驗市場:各檢查
  • 早產及PROM檢驗市場:各地區

第7章 亞太地區的早產及PROM檢驗市場

  • 市場概要
  • 早產及PROM檢驗市場:各檢查
  • 早產及PROM檢驗市場:各地區

第8章 南美的早產及PROM檢驗市場

  • 市場概要
  • 早產及PROM檢驗市場:各檢查
  • 早產及PROM檢驗市場:各地區

第9章 中東、非洲的早產及PROM檢驗市場

  • 市場概要
  • 早產及PROM檢驗市場:各檢查
  • 早產及PROM檢驗市場:各地區

第10章 企業簡介

  • Abbott Laboratories, Inc.
  • Biosynex
  • Clinical Innovations, LLC
  • CooperSurgical, Inc.
  • Hologic, Inc.
  • IQ Products.
  • Medixbiochemica
  • NX Prenatal, Inc.
  • Qiagen N.V.
  • Sera Prognostics, Inc.
Product Code: 138654-08-22

Industry Outlook

The preterm birth and PROM testing market is set to growth at a compounded annual growth rate (CAGR) of 2.1% during the forecast period from 2022 to 2030. As per the research findings of World Health Organization (WHO), annually 15 million babies are born before the completion of 37 weeks of normal pregnancy and as a result approximately 1 million children die every year due to complications associated with preterm births.

Excellent diagnostic accuracy and sensitivity will increase the popularity of biomarkers as PROM testing kits

Physicians investigate preliminary symptoms such as vaginal bleeding, vaginal discharge, pelvic pressure etc., to confirm preterm birth complications. Pelvic examination is the first line of diagnostic approach which is performed several times over a period of time to study the contraction and changes of cervix. If the cervix begins to soften, dilate and become thin before 37 weeks of pregnancy the patient is diagnosed with preterm labor. Biomarkers such as Alpha-fetoprotein test (AFT), insulin like growth factor binding protein-1 (IGFBP-1), placental alpha macroglobulin-1 (PAMG-1) etc., are gaining tremendous attention in the last decade. Excellent diagnostic accuracy and sensitivity increases the popularity of biomarkers as PROM testing kits.

Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region

In the present scenario North America is leading the regional segment for preterm birth and PROM testing market with a share of 36%. Annually 3.9 million babies are born in North America of which 12.0% are born prematurely. Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region. Existence of major players such as Abbott Laboratories, Inc., CooperSurgical, Inc., Qiagen, Inc., Hologic, Inc. etc. further propel the market growth in North America region. Europe is the second largest market with a share of 28% on account of supportive regulatory environment provided by the European Medical Agency (EMA) for PROM testing kits and establishment of well-developed healthcare infrastructure. Asia Pacific currently holds 15% market share and will be showcasing rapid growth in the near future owing to increasing complication related to pregnancy and proactive government initiatives to provide optimum maternal care.

Biopharmaceutical companies specializing in manufacturing preterm birth and PROM testing kits are: Abbott Laboratories, Inc., Biosynex, Clinical Innovations, LLC, CooperSurgical, Inc., Hologic, Inc., IQ Products, Medixbiochemica, NX Prenatal, Inc., Qiagen N.V. and Sera Prognostics, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Preterm Birth And PROM Testing market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Preterm Birth And PROM Testing market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Test

  • Pelvic Exam
  • Ferning Test
  • Nitrazine Test
  • Pooling Test
  • Ultrasound Test
  • Uterine Monitoring Test
  • Biomarkers

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Preterm Birth And PROM Testing market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Preterm Birth And PROM Testing market?
  • Which is the largest regional market for Preterm Birth And PROM Testing market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Preterm Birth And PROM Testing market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Preterm Birth And PROM Testing market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Preterm Birth And PROM Testing Market
  • 2.2. Global Preterm Birth And PROM Testing Market, By Test, 2021 (US$ Million)
  • 2.3. Global Preterm Birth And PROM Testing Market, By Geography, 2021 (US$ Million)
  • 2.4. Impact of Covid 19
  • 2.5. Attractive Investment Proposition by Geography, 2021
  • 2.6. Competitive Analysis
    • 2.6.1. Market Positioning of Key Preterm Birth And PROM Testing Market Vendors
    • 2.6.2. Strategies Adopted by Preterm Birth And PROM Testing Market Vendors
    • 2.6.3. Key Industry Strategies

3. Preterm Birth And PROM Testing Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Preterm Birth And PROM Testing Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Pelvic Exam
    • 4.3.2. Ferning Test
    • 4.3.3. Nitrazine Test
    • 4.3.4. Pooling Test
    • 4.3.5. Ultrasound Test
    • 4.3.6. Uterine Monitoring Test
    • 4.3.7. Biomarkers

5. North America Preterm Birth And PROM Testing Market, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)
  • 5.3.Preterm Birth And PROM Testing Market: By Region, 2020-2030, USD (Million)
    • 5.3.1.North America
      • 5.3.1.1. U.S.
      • 5.3.1.2. Canada
      • 5.3.1.3. Rest of North America

6. UK and European Union Preterm Birth And PROM Testing Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)
  • 6.3.Preterm Birth And PROM Testing Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.UK and European Union
      • 6.3.1.1. UK
      • 6.3.1.2. Germany
      • 6.3.1.3. Spain
      • 6.3.1.4. Italy
      • 6.3.1.5. France
      • 6.3.1.6. Rest of Europe

7. Asia Pacific Preterm Birth And PROM Testing Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)
  • 7.3.Preterm Birth And PROM Testing Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.Asia Pacific
      • 7.3.1.1. China
      • 7.3.1.2. Japan
      • 7.3.1.3. India
      • 7.3.1.4. Australia
      • 7.3.1.5. South Korea
      • 7.3.1.6. Rest of Asia Pacific

8. Latin America Preterm Birth And PROM Testing Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)
  • 8.3.Preterm Birth And PROM Testing Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Latin America
      • 8.3.1.1. Brazil
      • 8.3.1.2. Mexico
      • 8.3.1.3. Rest of Latin America

9. Middle East and Africa Preterm Birth And PROM Testing Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)
  • 9.3.Preterm Birth And PROM Testing Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Middle East and Africa
      • 9.3.1.1. GCC
      • 9.3.1.2. Africa
      • 9.3.1.3. Rest of Middle East and Africa

10. Company Profile

  • 10.1. Abbott Laboratories, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Portfolio
    • 10.1.4. Strategic Initiatives
  • 10.2. Biosynex
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Portfolio
    • 10.2.4. Strategic Initiatives
  • 10.3. Clinical Innovations, LLC
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Portfolio
    • 10.3.4. Strategic Initiatives
  • 10.4. CooperSurgical, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Portfolio
    • 10.4.4. Strategic Initiatives
  • 10.5. Hologic, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Portfolio
    • 10.5.4. Strategic Initiatives
  • 10.6. IQ Products.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Portfolio
    • 10.6.4. Strategic Initiatives
  • 10.7. Medixbiochemica
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Portfolio
    • 10.7.4. Strategic Initiatives
  • 10.8. NX Prenatal, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Portfolio
    • 10.8.4. Strategic Initiatives
  • 10.9. Qiagen N.V.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Portfolio
    • 10.9.4. Strategic Initiatives
  • 10.10. Sera Prognostics, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Portfolio
    • 10.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)
  • TABLE 2 North America Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)
  • TABLE 3 UK and European Union Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)
  • TABLE 4 Asia Pacific Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)
  • TABLE 5 Latin America Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)
  • TABLE 6 Middle East and Africa Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Preterm Birth And PROM Testing Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Preterm Birth And PROM Testing Market: Quality Assurance
  • FIG. 5 Global Preterm Birth And PROM Testing Market, By Test, 2021
  • FIG. 6 Global Preterm Birth And PROM Testing Market, By Geography, 2021
  • FIG. 7 Global Preterm Birth And PROM Testing Market, By Test, 2021 Vs 2030, %
  • FIG. 8 U.S. Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 9 Canada Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 10 Rest of North America Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 11 UK Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 12 Germany Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 13 Spain Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 14 Italy Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 15 France Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 16 Rest of Europe Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 17 China Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 18 Japan Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 19 India Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 20 Australia Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 21 South Korea Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 22 Rest of Asia Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 23 Brazil Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 24 Mexico Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Latin America Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 26 GCC Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 27 Africa Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Middle East and Africa Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030